ASRS recap: Presentations from 16 July
KALAHARI study update; novel surgical approaches for progressive retinal detachments; and a new risk is identified for CST fluctuations.
Dr Matthew Starr presented, “Factors Associated With Fluctuations in Central Subfield Thickness in Patients With Diabetic Macular Oedema Using 2 Clinical Trial Databases.”
Investigating surgical approaches for progressive retinal detachments secondary to retinoschisis
Progressive symptomatic retinal detachment complicating degenerative retinoschisis (PSRSCR) is a rare complication of degenerative retinoschisis, but the treatment success rate following a single surgery is low compared with uncomplicated rhegmatogenous RDs.
J. Fernando Arevalo, MD, PhD, The Edmund F. and Virginia B. Ball Professor of Ophthalmology Chairman of Ophthalmology at Johns Hopkins Bayview Medical Center, Wilmer Eye Institute, Johns Hopkins University, Baltimore, investigated the anatomic and functional outcomes of pars plana vitrectomy (PPV), scleral buckle (SB), or a combination of the two, and suggested that the combination approach may need further consideration.
Dr Rahul Khurana discusses his 2022 ASRS talk, “Phase 2 Study of THR-149, a Plasma Kallikrein Inhibitor in Patients With DME Who Respond Suboptimally to Anti-VEGF Treatment (Month 6 Results of Part A of the KALAHARI Study),” which he presented in New York City, New York.
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
